Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Origin Materials (ORGN) Cash & Equivalents (2020 - 2025)

Origin Materials' Cash & Equivalents history spans 5 years, with the latest figure at $32.9 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 41.53% to $32.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.9 million, a 41.53% decrease, with the full-year FY2025 number at $32.9 million, down 41.53% from a year prior.
  • Cash & Equivalents hit $32.9 million in Q4 2025 for Origin Materials, down from $34.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ORGN hit a ceiling of $107.9 million in Q4 2022 and a floor of $32.9 million in Q4 2025.
  • Historically, Cash & Equivalents has averaged $63.5 million across 5 years, with a median of $57.9 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: surged 131.27% in 2022 and later plummeted 42.15% in 2025.
  • Tracing ORGN's Cash & Equivalents over 5 years: stood at $46.6 million in 2021, then surged by 131.27% to $107.9 million in 2022, then dropped by 30.0% to $75.5 million in 2023, then dropped by 25.42% to $56.3 million in 2024, then tumbled by 41.53% to $32.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for ORGN at $32.9 million in Q4 2025, $34.1 million in Q3 2025, and $35.3 million in Q2 2025.